Decheng Capital LLC Portfolio Holdings

Decheng Capital LLC

  • $396 Billion
  • Q2 2025

Decheng Capital LLC has filed its 13F form on August 13, 2025 for Q2 2025 where it was disclosed a total value porftolio of $396 Billion distributed in 25 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Cg Oncology Inc with a value of $166B, Aardvark Therapeutics Inc with a value of $53B, Nuvation Bio Inc. with a value of $50.6B, Upstream Bio Inc. with a value of $36.1B, and Newamsterdam Pharma CO Nv Shs with a value of $13.9B.

Examining the 13F form we can see an increase of $39.5B in the current position value, from $356B to 396B.

Decheng Capital LLC is based out at Menlo Park, CA

Below you can find more details about Decheng Capital LLC portfolio as well as his latest detailed transactions.

Portfolio value $396 Billion
Healthcare: $118 Billion

Stock Holdings Table Market Cap. of $200 Billions or more

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 25
  • Current Value $396 Billion
  • Prior Value $356 Billion
  • Filing
  • Period Q2 2025
  • Filing Date August 13, 2025
  • Form Type 13F-HR
  • Activity in Q2 2025
  • New Purchases 1 stocks
  • Additional Purchases 3 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 8 stocks
Track This Portfolio

Track Decheng Capital LLC Portfolio

Follow Decheng Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Decheng Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Decheng Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email